Sign in
4

Changes in Ownership

CNS Pharmaceuticals, Inc. Filed Acc 0001683168-21-002999

Options or other derivatives

  • Director acquired 32,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Andraczke Andrzej · Director

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2021-07-15 Grant or award : show line 1 in the form Option to purchase common stock +32,000 178,559 D
Loading xslF345X03/ownership.xml…